Skip to main content

Table 2 Clinical characteristics of participants at the end of follow-up

From: Increased C4 and decreased C3 levels are associated with a poor prognosis in patients with immunoglobulin A nephropathy: a retrospective study

Clinical characteristics
Duration of follow-up (months, median [IQR]) 35 (11)
Serum creatinine (μmol/L, median [IQR]) 78 (41)
UPCR (g/g, median [IQR]) 0.5 (1.0)
eGFR (ml/min/1.73m2, mean [SD]) 91.1 (34.7)
ESRD (n [%]) 16 (4.0)
Endpoint event (n [%]) 39 (9.8)
Immunosuppressive therapy (n [%]) 202 (50.1)
ACEI/ARB (n [%]) 255 (87.3)
  1. SD standard deviation, IQR interquartile range